| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 8,360 | 4,613 | | Cost of Revenue | 1,756 | 1,144 | | | Gross Profit | 6,605 | 3,469 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 289 | 137 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 6,316 | 3,333 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (98,012) | (26,300) | | Earnings Before Interest And Taxes | 6,316 | 3,333 | | Interest Expense |
-
|
-
| | Income Before Tax | 6,316 | 3,333 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (91,697) | (22,968) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (91,697) | (22,968) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($91,697) | ($22,968) |
|
0.03% Nasdaq 
Income Statement
